Related Experiment Videos

Interactions of trimebutine with guinea-pig opioid receptors

Insights

Trimebutine (TMB) and its metabolite N-desmethyl trimebutine (NDTMB) are weak opioid agonists with higher affinity for mu receptors. Peripheral opioid receptors mediate their gastrointestinal effects.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Neuroscience

Background:

  • Trimebutine (TMB) and its active metabolite N-desmethyl trimebutine (NDTMB) are commonly used to treat gastrointestinal motility disorders.
  • Opioid receptors, including mu, delta, and kappa subtypes, play a significant role in regulating gastrointestinal function.

Purpose of the Study:

  • To investigate the binding affinities of TMB and NDTMB to mu, delta, and kappa opioid receptor subtypes.
  • To characterize the opioid receptor interaction profile of TMB and NDTMB and compare it to morphine.

Main Methods:

  • Radioligand binding assays using specific 3H-ligands were performed on guinea-pig membrane preparations.
  • Affinity and selectivity for opioid receptor subtypes were determined.
  • Sodium shift ratios were measured to assess functional activity.

Main Results:

  • TMB and NDTMB exhibited higher affinity for the mu opioid receptor subtype compared to delta and kappa subtypes.
  • TMB and NDTMB were less potent than morphine at the mu receptor, showing 30-fold and 48-fold lower activity, respectively.
  • Receptor selectivity indices indicated a distinct binding profile for TMB and NDTMB compared to morphine, with TMB (100:12:14.4) and NDTMB (100:32:25) showing different selectivity patterns than morphine (100:5:5).
  • Sodium shift ratios were lower for TMB (14) and NDTMB (10) than for morphine (37), suggesting weaker agonist activity.

Conclusions:

  • TMB and NDTMB can be classified as weak opioid agonists, unlike morphine, a pure mu agonist.
  • These findings confirm that peripheral opioid receptors are involved in mediating the gastrointestinal motility effects of TMB and NDTMB.

Related Concept Videos